SCIENCE: Clinical assessment of dysphagia in neurodegeneration (CADN): development, validity and reliability of a bedside tool for dysphagia assessment

The CADN is a reliable, valid, brief, quantifiable, and easily deployed assessment of swallowing in neurodegenerative disease. It is thus ideally suited for both clinical bedside assessment and future multicentre clinical trials in neurodegenerative disease.

 

Click here for more details.

Tags: , , ,

Related Post

Redenlab contributes to position paper on advancing digital healthtechnologies for frontotemporal degeneration

  • Posted on 15 May, 2025
    MEDIA RELEASE MELBOURNE, VIC – A major collaborative paper published in Alzheimer’s & Dementia introduces a critical roadmap for the...
    Read more

    Expanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals

    • Posted on 31 March, 2024
      Speech and language impairments are core features of the neurodevelopmental genetic condition Kleefstra syndrome. The speech, language and cognitive profile...
      Read more

      Acoustic analysis of the effects of sustained wakefulness on speech

      • Posted on 25 January, 2024
        Exposing healthy adults to extended periods of wakefulness is known to induce changes in psychomotor functioning. The effect of fatigue...
        Read more